Epizyme, Inc. (EPZM) has 107 open-market insider trades by 33 insiders since 2013. The most active filer is Peter Tai-Ching Ho.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| RPI Finance Trust | Dir10% Owner | — | 1 | $68.0M | 2022-01-31 |
| Carl Goldfischer | Dir | — | 6 | $40.7M | 2022-08-12 |
| David M. Mott | Dir | — | 11 | $39.2M | 2022-08-12 |
| M. James Barrett | 10% Owner | — | 4 | $24.1M | 2016-01-12 |
| Forest Baskett | 10% Owner | — | 4 | $24.1M | 2016-01-12 |
| Peter J. Barris | 10% | — | 4 | $24.1M | 2016-01-12 |
| Scott D. Sandell | 10% Owner | — | 4 | $24.1M | 2016-01-12 |
| Krishna Kittu Kolluri | 10% Owner | — | 4 | $24.0M | 2016-01-12 |
| Ravi Viswanathan | 10% Owner | — | 4 | $24.0M | 2016-01-12 |
| Patrick J. Kerins | 10% Owner | — | 3 | $24.0M | 2016-01-12 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Jeffery Kutok | Chief Scientific Officer | Sell | $2K | 2022-04-11 |
| Joseph Beaulieu | Controller | Sell | $333 | 2022-02-07 |
| Shefali Agarwal | — | Sell | $2K | 2022-02-07 |
| Joseph Beaulieu | Controller | Sell | $941 | 2022-02-02 |
| Jeffery Kutok | Chief Scientific Officer | Sell | $4K | 2022-02-02 |
| Shefali Agarwal | — | Sell | $4K |
Companies that share insiders with EPZM, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2022-02-02 |
| RPI Finance Trust | Director & 10% Owner | Buy | $68.0M | 2022-01-31 |
| Shefali Agarwal | — | Sell | $6K | 2022-01-26 |
| Shefali Agarwal | — | Sell | $5K | 2021-12-06 |
| Jeffery Kutok | Chief Scientific Officer | Sell | $18K | 2021-04-05 |
| David M. Mott | Director | Buy | $999K | 2021-03-25 |
| Robert B. Bazemore | CEO & President | Sell | $162K | 2021-03-25 |
| Shefali Agarwal | Chief Medical Officer | Sell | $11K | 2021-02-04 |
| Matthew Ros | — | Sell | $10K | 2021-02-04 |
| Paolo Tombesi | CFO | Sell | $11K | 2021-02-04 |